Cargando…

Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome

Studies concerning the role of arachidonic acid (AA) and its metabolites in kidney disease are scarce, and this applies in particular to idiopathic nephrotic syndrome (INS). INS is one of the most frequent glomerular diseases in childhood; it is characterized by T-lymphocyte dysfunction, alterations...

Descripción completa

Detalles Bibliográficos
Autores principales: Turolo, Stefano, Edefonti, Alberto, Mazzocchi, Alessandra, Syren, Marie Louise, Morello, William, Agostoni, Carlo, Montini, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196840/
https://www.ncbi.nlm.nih.gov/pubmed/34064238
http://dx.doi.org/10.3390/ijms22115452
_version_ 1783706780147122176
author Turolo, Stefano
Edefonti, Alberto
Mazzocchi, Alessandra
Syren, Marie Louise
Morello, William
Agostoni, Carlo
Montini, Giovanni
author_facet Turolo, Stefano
Edefonti, Alberto
Mazzocchi, Alessandra
Syren, Marie Louise
Morello, William
Agostoni, Carlo
Montini, Giovanni
author_sort Turolo, Stefano
collection PubMed
description Studies concerning the role of arachidonic acid (AA) and its metabolites in kidney disease are scarce, and this applies in particular to idiopathic nephrotic syndrome (INS). INS is one of the most frequent glomerular diseases in childhood; it is characterized by T-lymphocyte dysfunction, alterations of pro- and anti-coagulant factor levels, and increased platelet count and aggregation, leading to thrombophilia. AA and its metabolites are involved in several biological processes. Herein, we describe the main fields where they may play a significant role, particularly as it pertains to their effects on the kidney and the mechanisms underlying INS. AA and its metabolites influence cell membrane fluidity and permeability, modulate platelet activity and coagulation, regulate lymphocyte activity and inflammation, preserve the permeability of the glomerular barrier, influence podocyte physiology, and play a role in renal fibrosis. We also provide suggestions regarding dietary measures that are able to prevent an imbalance between arachidonic acid and its parental compound linoleic acid, in order to counteract the inflammatory state which characterizes numerous kidney diseases. On this basis, studies of AA in kidney disease appear as an important field to explore, with possible relevant results at the biological, dietary, and pharmacological level, in the final perspective for AA to modulate INS clinical manifestations.
format Online
Article
Text
id pubmed-8196840
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81968402021-06-13 Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome Turolo, Stefano Edefonti, Alberto Mazzocchi, Alessandra Syren, Marie Louise Morello, William Agostoni, Carlo Montini, Giovanni Int J Mol Sci Review Studies concerning the role of arachidonic acid (AA) and its metabolites in kidney disease are scarce, and this applies in particular to idiopathic nephrotic syndrome (INS). INS is one of the most frequent glomerular diseases in childhood; it is characterized by T-lymphocyte dysfunction, alterations of pro- and anti-coagulant factor levels, and increased platelet count and aggregation, leading to thrombophilia. AA and its metabolites are involved in several biological processes. Herein, we describe the main fields where they may play a significant role, particularly as it pertains to their effects on the kidney and the mechanisms underlying INS. AA and its metabolites influence cell membrane fluidity and permeability, modulate platelet activity and coagulation, regulate lymphocyte activity and inflammation, preserve the permeability of the glomerular barrier, influence podocyte physiology, and play a role in renal fibrosis. We also provide suggestions regarding dietary measures that are able to prevent an imbalance between arachidonic acid and its parental compound linoleic acid, in order to counteract the inflammatory state which characterizes numerous kidney diseases. On this basis, studies of AA in kidney disease appear as an important field to explore, with possible relevant results at the biological, dietary, and pharmacological level, in the final perspective for AA to modulate INS clinical manifestations. MDPI 2021-05-21 /pmc/articles/PMC8196840/ /pubmed/34064238 http://dx.doi.org/10.3390/ijms22115452 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Turolo, Stefano
Edefonti, Alberto
Mazzocchi, Alessandra
Syren, Marie Louise
Morello, William
Agostoni, Carlo
Montini, Giovanni
Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
title Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
title_full Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
title_fullStr Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
title_full_unstemmed Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
title_short Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
title_sort role of arachidonic acid and its metabolites in the biological and clinical manifestations of idiopathic nephrotic syndrome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196840/
https://www.ncbi.nlm.nih.gov/pubmed/34064238
http://dx.doi.org/10.3390/ijms22115452
work_keys_str_mv AT turolostefano roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome
AT edefontialberto roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome
AT mazzocchialessandra roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome
AT syrenmarielouise roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome
AT morellowilliam roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome
AT agostonicarlo roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome
AT montinigiovanni roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome